哈莫尼生物科学

Manufacturing · Pharmaceutical Preparations

完成交易日收盘US$37.02-2.35%行情日期 2026-11-03 · 非实时

公开资料页汇总哈莫尼生物科学（HRMY）的已发布行情、估值、风险、财务摘要与同业对比。行情截至2026-11-03，非实时；缺失值不按零处理。

股价走势

复权收盘价（美元）

2025-10-31 — 2026-11-03253 个交易日样本

查看交易日数据

2026-11-03HRMYUS$37.02

查看图表数据

日期	HRMY
2025-10-31	28.57
2025-11-03	29.33
2025-11-04	30.72
2025-11-05	31.35
2025-11-06	30.94
2025-11-07	31.43
2025-11-10	31.82
2025-11-11	32.98
2025-11-12	33.54
2025-11-13	34.29
2025-11-14	34.03
2025-11-17	33.99
2025-11-18	33.99
2025-11-19	33.31
2025-11-20	33.39
2025-11-21	34.31
2025-11-24	35.27
2025-11-25	35.34
2025-11-26	35.56
2025-11-28	35.29
2025-12-01	35.51
2025-12-02	36.01
2025-12-03	37
2025-12-04	38.25
2025-12-05	39.83
2025-12-08	38.92
2025-12-09	38.82
2025-12-10	39.27
2025-12-11	39.59
2025-12-12	40.51
2025-12-15	38.92
2025-12-16	38.83
2025-12-17	38.78
2025-12-18	37.47
2025-12-19	37.81
2025-12-22	38.86
2025-12-23	38.44
2025-12-24	38.49
2025-12-26	38.13
2025-12-29	37.91
2025-12-30	37.64
2025-12-31	37.42
2026-01-02	37.38
2026-01-05	36.75
2026-01-06	36.75
2026-01-07	37.55
2026-01-08	37.87
2026-01-09	38.55
2026-01-12	38.27
2026-01-13	35.76
2026-01-14	36.04
2026-01-15	36.41
2026-01-16	36.22
2026-01-20	35.91
2026-01-21	36.69
2026-01-22	36.76
2026-01-23	36.82
2026-01-26	37.36
2026-01-27	37.68
2026-01-28	36.84
2026-01-29	36.86
2026-01-30	36.52
2026-02-02	37.84
2026-02-03	37.48
2026-02-04	37.32
2026-02-05	36.41
2026-02-06	37.27
2026-02-09	37.08
2026-02-10	37.93
2026-02-11	36.59
2026-02-12	35.85
2026-02-13	36.01
2026-02-17	36.92
2026-02-18	35.28
2026-02-19	34.39
2026-02-20	29.16
2026-02-23	26.87
2026-02-24	28.19
2026-02-25	28.19
2026-02-26	29.05
2026-02-27	28.54
2026-03-02	28.9
2026-03-03	28.27
2026-03-04	28.54
2026-03-05	28.51
2026-03-06	28.33
2026-03-09	28.57
2026-03-10	28.74
2026-03-11	28.79
2026-03-12	27.79
2026-03-13	27.61
2026-03-16	27.86
2026-03-17	28.37
2026-03-18	27.85
2026-03-19	27.81
2026-03-20	27.72
2026-03-23	27.6
2026-03-24	27.1
2026-03-25	27.59
2026-03-26	27.44
2026-03-27	26.54
2026-03-30	26.9
2026-03-31	28.01
2026-04-01	27.96
2026-04-02	27.74
2026-04-06	27.71
2026-04-07	27.62
2026-04-08	28.47
2026-04-09	29.16
2026-04-10	28.89
2026-04-13	29.05
2026-04-14	29.29
2026-04-15	29.22
2026-04-16	29.42
2026-04-17	29.99
2026-04-20	29.53
2026-04-21	32.14
2026-04-22	31.97
2026-04-23	32.08
2026-04-24	30.8
2026-04-27	31.05
2026-04-28	31.16
2026-04-29	31.05
2026-04-30	31.26
2026-05-01	31.83
2026-05-04	32.59
2026-05-05	32.34
2026-05-06	32.78
2026-05-07	31.42
2026-05-08	30.99
2026-05-11	30.18
2026-05-12	30.15
2026-05-13	30.83
2026-05-14	30.76
2026-05-15	30.09
2026-05-18	29.83
2026-05-19	30.44
2026-05-20	31.38
2026-05-21	30.49
2026-05-22	30.15
2026-05-26	30.09
2026-05-27	30.76
2026-05-28	31.49
2026-05-29	31.59
2026-06-01	31.81
2026-06-02	30.91
2026-06-03	32.1
2026-06-04	32.96
2026-06-05	32.2
2026-06-08	32.39
2026-06-09	34.1
2026-06-10	35.48
2026-06-11	35.2
2026-06-12	34.46
2026-06-15	34.18
2026-06-16	33.83
2026-06-17	33.77
2026-06-18	33.28
2026-06-22	33.43
2026-06-23	34.16
2026-06-24	34.45
2026-06-25	34.13
2026-06-26	35.47
2026-06-29	35.34
2026-06-30	36.41
2026-07-01	36
2026-07-02	37.26
2026-07-06	37.01
2026-07-07	38.26
2026-07-08	38.08
2026-07-09	38.21
2026-07-10	36.84
2026-07-13	35.54
2026-07-14	34.81
2026-07-15	34.9
2026-07-16	33.53
2026-07-17	33.77
2026-07-20	33.5
2026-07-21	36.84
2026-07-22	34.86
2026-07-23	35.8
2026-07-24	35.32
2026-07-27	36.01
2026-07-28	35.77
2026-07-29	35.86
2026-07-30	35.86
2026-07-31	35.24
2026-08-03	35.6
2026-08-04	38.78
2026-08-05	38.24
2026-08-06	38.75
2026-08-07	38.41
2026-08-10	39
2026-08-11	39.52
2026-08-12	39.77
2026-08-13	38.5
2026-08-14	38.12
2026-08-17	38.14
2026-08-18	38.83
2026-08-19	39.93
2026-08-20	38.07
2026-08-21	38.15
2026-08-24	38.5
2026-08-25	38.95
2026-08-26	39.66
2026-08-27	39.87
2026-08-28	39.21
2026-08-31	39.38
2026-09-01	41.25
2026-09-02	42.86
2026-09-03	41.86
2026-09-04	42.25
2026-09-08	42.07
2026-09-09	41.62
2026-09-10	41.1
2026-09-11	41.52
2026-09-14	41.54
2026-09-15	42.17
2026-09-16	42.21
2026-09-17	42.74
2026-09-18	42.02
2026-09-21	42.1
2026-09-22	41.53
2026-09-23	40.48
2026-09-24	41.16
2026-09-25	41.26
2026-09-28	40.01
2026-09-29	39.29
2026-09-30	39.26
2026-10-01	39.57
2026-10-02	39.64
2026-10-05	39.92
2026-10-06	39.36
2026-10-07	39.34
2026-10-08	39.6
2026-10-09	40.28
2026-10-12	38.23
2026-10-13	37.03
2026-10-14	37.51
2026-10-15	38.27
2026-10-16	37.95
2026-10-19	37.54
2026-10-20	38.7
2026-10-21	38.31
2026-10-22	36.03
2026-10-23	36.13
2026-10-26	36.83
2026-10-27	37.95
2026-10-28	38.5
2026-10-29	38.59
2026-10-30	38.76
2026-11-02	37.91
2026-11-03	37.02

1、3、6、12个月分别按21、63、126、252个交易日取区间；缺失日期不从区间外补齐。

使用已有每日复权收盘样本，非实时行情；图中价格可能与未复权收盘报价不同。

01 · MARKET FRAME

行情、估值与风险

基于已完成交易日和已发布财务资料

市值US$2.2B

市盈率（TTM）11.9×

自由现金流收益率+16.1%

距52周高点-13.6%

近一年波动率+39.9%

近一年最大回撤-34.5%

区间涨跌幅

10日-4.3%起点 2026-10-20

30日-10.9%起点 2026-09-22

90日+4.4%起点 2026-06-26

180日+0.3%起点 2026-02-17

250日+20.5%起点 2025-11-04

区间涨跌幅使用复权收盘价；估值和风险指标缺失时显示为—，不按零处理。

02 · FINANCIAL TRACE

财务摘要

公开页仅显示最近3个已校验报告期

年度财务走势

百万美元 · 年度报告期

查看报告期数据

2025-12-31营收868.5百万美元

指标	2026-07-31	2026-06-30	2025-12-31	2025-08-01	2025-06-30	2024-12-31	2024-08-02	2024-06-30	2023-12-31
营收	—	—	868.5	—	—	714.7	—	—	582
净利润	—	—	158.7	—	—	145.5	—	—	128.9
自由现金流	—	—	347.9	—	—	218.7	—	—	219.1
股份数	58.2	—	—	57.5	—	—	56.8	—	—
债务	—	154	—	—	172.1	—	—	186.4	—
总资产	—	1,373.1	—	—	1,108	—	—	858.4	—

客户合同口径 · 营收采用客户合同口径，可能不等同于公司全部收入。

金额及股份数均以百万为单位。缺失或待核验数据不按零处理。

03 · PEER SET

同业对比

同一细分行业中市值最接近的公司

公司	市值	近250日涨跌幅	市盈率	距52周高点	波动率
PRGO培瑞克	US$2.2B	-14.9%	—	-17.1%	+55.9%
ZYME泽美沃克斯	US$2.1B	+65.9%	—	-3%	+54.3%
LKFTLakefront Biotherapeutics NV	US$2.1B	+5.6%	—	-7.2%	+27.5%
PVLA帕尔维拉治疗	US$2.2B	+103.7%	—	-3.3%	+83.1%

同业由已覆盖公司的行业分类和市值接近度确定，仅用于横向研究；缺失数据不按零处理。